CAJ | 학술논문

2007年10月28日，我国批准了《关于（与贸易有关的知识产权协定）修正案议定书》（简称《议定书》），《议定书》是2001年11月启动的WTO多哈回合谈判至今取得的惟一一项具体成果，是WTO成立以来几十个生效协定的首次重要修订。《议定书》放宽了对专利强制许可药品出口的限制，消除了符合强制许可规定的专利药品国际贸易的法律障碍，为发展中成员、最不发达成员通过进口获得更便宜的必须药品，解决公共健康危机提供了便利。
2007년10월28일，아국비준료《관우（여무역유관적지식산권협정）수정안의정서》（간칭《의정서》），《의정서》시2001년11월계동적WTO다합회합담판지금취득적유일일항구체성과，시WTO성립이래궤십개생효협정적수차중요수정。《의정서》방관료대전리강제허가약품출구적한제，소제료부합강제허가규정적전리약품국제무역적법률장애，위발전중성원、최불발체성원통과진구획득경편의적필수약품，해결공공건강위궤제공료편리。
On 28 October, 2007, Chinese government approved the Decision on the Amendment of the TRIPS Agreement. As the only achievement of Doha Ministerial Conferences initiated in December 2001, the Decision is the first significant modification of one of the operative WTO agreements from the establishment of the organization. The Decision provides exporting flexibilities and clears up the legal barriers for international trade of compulsory license patented medicines, which benefits the developing and least developed members in importing the necessary medicines at a lower cost to deal with national wide public health emergency.